Sunday 18 October 2026
Export PLRZ’s income statement to Excel — free account
Polyrizon Ltd.
PLRZ Healthcare Biotechnology
10.00
0.01
−0.10%
Follow PLRZ
| Jun '26 | Dec '25 | Jun '25 | Dec '24 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | 0.00% | 0.00% | — |
+3 more TTM periods Free account |
|
| 0.00% | 0.00% | 0.00% | — | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
— | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
— | (7.84) | (3.85) | (3.15) | |
Capital Expenditures |
— | (0.01) | 0.00 | — | |
| Other line items | |||||
Cash ROIC |
0.00% | (23.44%) | (11.25%) | (40.22%) | |
Operating CF/Net income |
— | 0.00 | 0.00 | 0.00 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 31.20 | 0.00 | |
Capex/Depreciation |
— | (0.01) | (0.02) | 0.00 | |
Operating CF per Share |
— | 0.00 | 0.00 | 0.00 | |
Capex per Share |
— | 0.00 | 0.00 | — | |
Capex to Sales |
— | 0.00 | 0.00 | — |
Columns are period end dates · fundamentals updated 30 Sep 2026